HOME > MARKETS > MARKET COMMENTARY
  MARKET COMMENTARY
EQUITY
Caplin Point Laboratories informs about press release
Dec-09-2025

Caplin Point Laboratories has informed that it enclosed Press Release on the company’s Subsidiary, Caplin Steriles, getting USFDA approval for its ANDA Linezolid Injection 600 mg/ 300 mL (2 mg/mL) Single Dose Infusion Bags.

The above information is a part of company’s filings submitted to BSE.

  RELATED NEWS >>